المؤلفون: Davey B. Daniel, Luis Paz-Ares, Mustafa Ozguroglu, Corinne Faivre-Finn, Scott J. Antonia, David R. Spigel, Phillip A. Dennis, Corey J. Langer, Cathy O'Brien, David Planchard, Shuji Murakami, David Vicente, Anna Rydén, Y. Zhang, Marina Chiara Garassino, Suresh Senan, Rina Hui, Alex Spira

المساهمون: Radiation Oncology, CCA - Cancer Treatment and quality of life

المصدر: Future Oncology, 17(10), 1165-1184. Future Medicine Ltd.
Garassino, M C, Paz-Ares, L, Hui, R, Faivre-Finn, C, Spira, A, Planchard, D, Ozguroglu, M, Daniel, D, Vicente, D, Murakami, S, Langer, C, Senan, S, Spigel, D, Ryden, A, Zhang, Y, O'Brien, C, Dennis, P A & Antonia, S J 2021, ' Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable, stage III non-small-cell lung cancer ', Future Oncology, vol. 17, no. 10, pp. 1165-1184 . https://doi.org/10.2217/fon-2020-1102Test
Garassino, M C, Paz-Ares, L, Hui, R, Faivre-Finn, C, Spira, A, Planchard, D, Özgüroğlu, M, Daniel, D, Vicente, D, Murakami, S, Langer, C, Senan, S, Spigel, D, Rydén, A, Zhang, Y, O'Brien, C, Dennis, P A & Antonia, S J 2021, ' Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable, stage III non-small-cell lung cancer ', Future Oncology, vol. 17, no. 10, pp. 1165-1184 . https://doi.org/10.2217/fon-2020-1102Test

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Durvalumab, durvalumab, Population, Placebo, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Patient Reported Outcome Measures, 030212 general & internal medicine, Stage (cooking), Lung cancer, education, programmed cell death ligand-1, Immune Checkpoint Inhibitors, Neoplasm Staging, Retrospective Studies, education.field_of_study, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Antibodies, Monoclonal, General Medicine, medicine.disease, humanities, Stage III Non-Small Cell Lung Cancer, Clinical trial, Treatment Outcome, patient-reported outcomes, 030220 oncology & carcinogenesis, Female, business, Chemoradiotherapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8996710d39bff8fe354388b7492bdc5bTest
https://research.vumc.nl/en/publications/c03a6381-5105-41ae-bdc3-fef7664d188bTest

المؤلفون: Rina Hui, Scott J. Antonia, Catherine Wadsworth, Suresh Senan, Bradford A. Perez, David Vicente, Davey B. Daniel, A. Villegas, Luis Paz-Ares, David R. Spigel, Mustafa Ozguroglu, Shuji Murakami, Corinne Faivre-Finn, Phillip A. Dennis, Helen Broadhurst, Corey J. Langer

المساهمون: Radiation Oncology, CCA - Cancer Treatment and quality of life

المصدر: Faivre-Finn, C, Spigel, D R, Senan, S, Langer, C, Perez, B A, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-Ares, L, Broadhurst, H, Wadsworth, C, Dennis, P A & Antonia, S J 2021, ' Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) ', Lung Cancer, vol. 151, pp. 30-38 . https://doi.org/10.1016/j.lungcan.2020.11.024Test
Lung Cancer, 151, 30-38. Elsevier Ireland Ltd
Faivre-finn, C, Spigel, D R, Senan, S, Langer, C, Perez, B A, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-ares, L, Broadhurst, H, Wadsworth, C, Dennis, P A & Antonia, S J 2020, ' Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) ', Lung Cancer . https://doi.org/10.1016/j.lungcan.2020.11.024Test

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Cancer Research, medicine.medical_specialty, Randomization, Durvalumab, Lung Neoplasms, Pd-L1 Expression, Docetaxel, Placebo, Vinorelbine, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Median follow-up, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Chemotherapy, Humans, Etoposide, Radiotherapy, business.industry, Antibodies, Monoclonal, Biomarker, Chemoradiotherapy, Concurrent, Carboplatin, Blockade, 030104 developmental biology, Nivolumab, Oncology, chemistry, 030220 oncology & carcinogenesis, Cell Lung-Cancer, Immunotherapy, Cisplatin, business, Non-small-cell lung cancer, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc66d1431e19641df7ad85c29d2fa5d3Test
https://research.vumc.nl/en/publications/a94e824c-5543-4cff-95c7-1dd8269a3f90Test

المؤلفون: Phillip A. Dennis, Michael Newton, Shuji Murakami, A. Villegas, M. Vincent, Mark A. Socinski, Helen Mann, Rina Hui, Scott J. Antonia, Davey B. Daniel, Keunchil Park, David Vicente, Mustafa Ozguroglu, Jhanelle E. Gray

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Male, Cancer Research, medicine.medical_specialty, Durvalumab, Lung Neoplasms, Survival, Immune-checkpoint inhibitors, Placebo, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, In patient, Patient Reported Outcome Measures, Lung cancer, Adverse effect, Aged, Patient-reported outcomes, business.industry, Hazard ratio, Antibodies, Monoclonal, Chemoradiotherapy, medicine.disease, Stage III Non-Small Cell Lung Cancer, Concurrent chemoradiotherapy, Exploratory analysis, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Safety, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76af519faebbedb9b884a946e8cbe4ffTest
https://hdl.handle.net/20.500.12831/6950Test

المؤلفون: Marina Chiara Garassino, Byoung-Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, Hervé Lena, Jesus Corral Jaime, Jhanelle E Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross A Soo, Yifan Huang, Catherine Wadsworth, Phillip A Dennis, Naiyer A Rizvi, Luis Paz-Ares Rodriguez, Silvia Novello, Sandrine Hiret, Peter Schmid, Eckart Laack, Raffaele Califano, Makoto Maemondo, Sang-We Kim, Jamie Chaft, David Vicente Baz, Thierry Berghmans, Dong-Wan Kim, Veerle Surmont, Martin Reck, Ji-Youn Han, Esther Holgado Martin, Cristobal Belda Iniesta, Yuichiro Oe, Antonio Chella, Akhil Chopra, Gilles Robinet, Hector Soto Parra, Michael Thomas, Parneet Cheema, Nobuyuki Katakami, Wu-Chou Su, Young-Chul Kim, Juergen Wolf, Jong-Seok Lee, Hideo Saka, Michele Milella, Inmaculada Ramos Garcia, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, Ernst Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Remi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoine Italiano, Dariusz Kowalski, Fabrice Barlesi, Yuh-Min Chen, David Spigel, Busyamas Chewaskulyong, Ramon Garcia Gomez, Rosa Alvarez Alvarez, Chih-Hsin Yang, Te-Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Koichi Goto, Joaquim Bosch-Barrera, Glen Weiss, Jean-Luc Canon, Christian Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius Waller, David Waterhouse, Bruno Coudert, Zsuzsanna Mark, Miyako Satouchi, Gee-Chen Chang, Christian Herzmann, Arvind Chaudhry, Selvaraj Giridharan, Paul Hesketh, Norihiko Ikeda, Ralph Boccia, Nichola Iannotti, Missak Haigentz, John Reynolds, John Querol, Kazuhiko Nakagawa, Shunichi Sugawara, Eng Huat Tan, Tomonori Hirashima, Scott Gettinger, Terufumi Kato, Koji Takeda, Oscar Juan Vidal, Andrea Mohn-Staudner, Amit Panwalkar, Davey Daniel, Kunihiko Kobayashi, Guia Elena Imelda Ladrera, Clemens Schulte, Martin Sebastian, Marketa Cernovska, Helena Coupkova, Libor Havel, Norbert Pauk, Joginder Singh, Shuji Murakami, Tibor Csoszi, Gyorgy Losonczy, Allan Price, Ian Anderson, Mussawar Iqbal, Vamsee Torri, Erzsebet Juhasz, Saleem Khanani, Leona Koubkova, Benjamin Levy, Ray Page, Csaba Bocskei, Lucio Crinò, David Einspahr, Christopher Hagenstad, Necy Juat, Lindsay Overton, Mitchell Garrison, Zsuzsanna Szalai

المساهمون: IRCCS Istituto Nazionale dei Tumori [Milano], Yonsei University College of Medicine, CHA Bundang Medical Center, Service Pneumologie-Allergologie [CHU Toulouse], Pôle Clinique des Voies respiratoires [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), University Hospitals KU Leuven, Chemistry, Oncogenesis, Stress and Signaling (COSS), Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospital Universitario Virgen del Rocío [Sevilla], H. Lee Moffitt Cancer Center and Research Institute, Carolina BioOncology Institute, Service de Pneumologie [CHI Créteil], CHI Créteil, IMRB - CEPIA/'Clinical Epidemiology And Ageing : Geriatrics, Primary Care and Public Health' [Créteil] (U955 Inserm - UPEC), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Azienda Ospedaliera San Gerardo, The Ottawa Hospital Research Institute, Centre for Rehabilitation Research and Development, 505 Smyth Road, Ottawa, ON, Canada, K1H 8M2., Samsung Medical Center Sungkyunkwan University School of Medicine, Institute Division of Hematology/Oncology, National University Hospital and National University Cancer Institute, AstraZeneca, Gaithersburg, MD, USA, AstraZeneca [Cambridge, UK], Columbia University [New York], Università degli studi di Torino = University of Turin (UNITO), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Department of Mathematics [Imperial College London], Imperial College London, Université libre de Bruxelles (ULB), Department of Microbiology, Chang Won National University, German Center for Lung Research, Università degli studi di Palermo - University of Palermo, Garassino, M, Cho, B, Kim, J, Mazieres, J, Vansteenkiste, J, Lena, H, Jaime, J, Gray, J, Powderly, J, Chouaid, C, Bidoli, P, Wheatley-Price, P, Park, K, Soo, R, Huang, Y, Wadsworth, C, Dennis, P, Rizvi, N

المصدر: Lancet Oncology
Lancet Oncology, 2020, 19 (4), pp.521-536. ⟨10.1016/s1470-2045(18)30144-x⟩
Lancet Oncol

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Durvalumab, Lung Neoplasms, Phases of clinical research, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Agents, Immunological, 4-Butyrolactone, Carcinoma, Non-Small-Cell Lung, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, Fatigue, Antibodies, Monoclonal, phase 2 study, gamma-Glutamyltransferase, Middle Aged, Progression-Free Survival, ErbB Receptors, ATLANTIS, Response Evaluation Criteria in Solid Tumors, Oncology, Durvalumab, non-small-cell lung cancer , ATLANTIS, phase 2 study, 030220 oncology & carcinogenesis, Cohort, Female, Immunotherapy, Diarrhea, medicine.medical_specialty, [SDV.CAN]Life Sciences [q-bio]/Cancer, Article, 03 medical and health sciences, Internal medicine, medicine, Humans, Progression-free survival, Aspartate Aminotransferases, Lung cancer, Aged, Performance status, business.industry, Pneumonia, medicine.disease, Injection Site Reaction, 030104 developmental biology, non-small-cell lung cancer, Mutation, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00025c91c5f85bf7d8b98d17aae85fd1Test
https://hal.u-pec.fr/hal-04145965/documentTest

المؤلفون: Diego Pérez Parente, L. Crama, Begoña Campos-Balea, David Vicente-Baz, Pedro Ruiz-Gracia, Manuel Cobo Dols, Javier de Castro Carpeño, Bartomeu Massuti

المساهمون: [Campos-Balea,B] Oncology, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain. [de Castro Carpeño,J] Oncology, Hospital Universitario La Paz, Madrid, Spain. [Massutí,B] Oncology, Hospital Universitario Alicante (ISABIAL), Alicante, Spain. [Vicente-Baz,D] Oncology, Hospital Universitario Virgen Macarena, Seville, Spain. [Pérez Parente, Ruiz-Gracia,P, Crama,L] Lung Cancer. Medical Affairs Department, Roche Farma S.A, Madrid, Spain. [Cobo Dols,M] Medical Oncology, Unidad de Gestión Clínica Intercentros de Oncología Médica. Hospitales Universitarios Regional y Virgen de la Victoria. IBIMA, Málaga, Spain.

المصدر: Thoracic Cancer, Vol 11, Iss 11, Pp 3357-3364 (2020)
Thoracic Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Lung adenocarcinoma, Male, Health Care::Environment and Public Health::Public Health::Epidemiologic Methods::Data Collection::Registries::SEER Program [Medical Subject Headings], Metastasis, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, Surveillance, Epidemiology, and End Results, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma [Medical Subject Headings], Neoplasm Metastasis, prognostic factor, Metástasis neoplásica, Persons::Persons::Age Groups::Adult::Aged [Medical Subject Headings], Cause of death, Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms [Medical Subject Headings], Hazard ratio, Pronóstico, General Medicine, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, 030220 oncology & carcinogenesis, Adenocarcinoma, Original Article, Female, non‐small cell lung cancer, Pulmonary and Respiratory Medicine, medicine.medical_specialty, overall survival, Check Tags::Male [Medical Subject Headings], Adenocarcinoma of Lung, Carcinoma de pulmón de células no pequeñas, Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms [Medical Subject Headings], lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasis [Medical Subject Headings], Adenocarcinoma del pulmón, medicine, metastasis, Humans, Lung cancer, non-small cell lung cancer, Aged, Proportional hazards model, business.industry, Cancer, Original Articles, Anatomy::Respiratory System::Lung [Medical Subject Headings], medicine.disease, 030104 developmental biology, Check Tags::Female [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings], business, SEER Program

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a93e514ffb8d138b51a3e8db263986fTest
https://hdl.handle.net/10668/16334Test

المؤلفون: David Planchard, Shuji Murakami, S.J. Antonia, Corey J. Langer, Anne-Marie Boothman, Helen Broadhurst, David Vicente, Byoung Chul Cho, Suresh Senan, C. Wadsworth, David Raben, Davey B. Daniel, Phillip A. Dennis, Alexander I. Spira, David R. Spigel, Bradford A. Perez, Corinne Faivre-Finn, Rina Hui, Luis Paz-Ares, Mustafa Ozguroglu, A. Villegas

المساهمون: İÜC, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radiation Oncology

المصدر: Ann Oncol
Paz-Ares, L, Spira, A, Raben, D, Planchard, D, Cho, B C, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Spigel, D, Senan, S, Langer, C J, Perez, B A, Boothman, A M, Broadhurst, H, Wadsworth, C, Dennis, P A, Antonia, S J & Faivre-Finn, C 2020, ' Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial ', Annals of Oncology, vol. 31, no. 6, pp. 798-806 . https://doi.org/10.1016/j.annonc.2020.03.287Test
Paz-Ares, L, Spira, A, Raben, D, Planchard, D, Cho, B C, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Spigel, D, Senan, S, Langer, C J, Boothman, A-M, Broadhurst, H, Wadsworth, C, Dennis, P A, Antonia, S J & Faivre-Finn, C 2020, ' Outcomes with durvalumab by tumour PD-L1 expression in unresectable, Stage III non-small-cell lung cancer in the PACIFIC trial ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 31, no. 6, pp. 798-806 . https://doi.org/10.1016/j.annonc.2020.03.287Test
Annals of oncology : official journal of the European Society for Medical Oncology, 31(6), 798-806. Oxford University Press

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Durvalumab, PACIFIC, Lung Neoplasms, durvalumab, stage III, PD-L1 expression, Placebo, Gastroenterology, Article, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Stage (cooking), Lung cancer, Proportional hazards model, business.industry, Hazard ratio, Antibodies, Monoclonal, Hematology, medicine.disease, Stage III Non-Small Cell Lung Cancer, 030104 developmental biology, Oncology, non-small-cell lung cancer, 030220 oncology & carcinogenesis, immunotherapy, business, Chemoradiotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2821de1574e6e128fc443bb253fe17d8Test
https://europepmc.org/articles/PMC8412232Test/

المؤلفون: Maria Jose Flor, David Vicente, Christoph Helwig, Luis Paz-Ares, Massimo Di Nicola, Tae Min Kim, Enriqueta Felip, James L. Gulley, Byoung Chul Cho, Laureen S. Ojalvo, Chia-Chi Lin, Rosa Maria Alvarez, Isabelle Dussault, Dae Ho Lee, Ki Hyeong Lee

المصدر: J Thorac Oncol

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, PD-L1, TGF-β, medicine.medical_specialty, M7824, Lung Neoplasms, medicine.medical_treatment, NSCLC, Gastroenterology, Article, B7-H1 Antigen, Bintrafusp alfa, 03 medical and health sciences, 0302 clinical medicine, Transforming Growth Factor beta, Internal medicine, Carcinoma, Non-Small-Cell Lung, Clinical endpoint, medicine, Humans, Adverse effect, business.industry, Antibodies, Monoclonal, Immunotherapy, Discontinuation, 030104 developmental biology, Oncology, Tolerability, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Cohort, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2d6615b1900eacd384b206400e01c8Test
http://www.jto.org/article/S1556086420301957/pdfTest

المؤلفون: Scott J. Antonia, A. Villegas, Alberto Chiappori, Catherine Wadsworth, David Planchard, Shuji Murakami, Maria Taboada, David R. Spigel, Luis Paz-Ares, Mustafa Ozguroglu, Davey B. Daniel, David Vicente, Ki Hyeong Lee, Takayasu Kurata, Johan Vansteenkiste, Byoung Chul Cho, Jhanelle E. Gray, Phillip A. Dennis, Corinne Faivre-Finn, Rina Hui

المساهمون: İÜC, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Durvalumab, PACIFIC, Lung Neoplasms, Population, Stage III NSCLC, Three-year update, Placebo, NSCLC, Gastroenterology, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Overall survival, education, Neoplasm Staging, education.field_of_study, business.industry, Hazard ratio, Antibodies, Monoclonal, Chemoradiotherapy, Confidence interval, Regimen, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, business

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1199512dca88a291a15bb416207a181fTest
https://hdl.handle.net/10668/14900Test

المؤلفون: David Vicente, J. Rigas, M. Tiseo, Johan Vansteenkiste, F. De Marinis, Maximilian Hochmair, M. Miranda, Giulio Metro, T. Geldart, K. Lamberg, Teresa Moran, A. Paredes, C. Nyhus, Antonio Santo, E. Hanrahan

المصدر: Tiseo, M, Santo, A, Hochmair, M J, Geldart, T, Metro, G, Hanrahan, E, Lamberg, K, Moran, T, Nyhus, C, Paredes, A, Vansteenkiste, J F, Vicente, D, Miranda, M, Rigas, J & de Marinis, F 2018, ' ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M-positive non-small cell lung cancer (NSCLC) European subset ', Annals of Oncology, vol. 29, no. Suppl. 8, pp. viii528 . https://doi.org/10.1093/annonc/mdy292.083Test

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, non-small cell lung cancer (NSCLC), EGFR T790M, Hematology, medicine.disease, Treatment study, Internal medicine, Medicine, Osimertinib, In patient, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f556ec92a8538d91ab8dc58b9867a9Test
https://portal.findresearcher.sdu.dk/da/publications/885d4b5b-ed23-4c05-9c3f-a3515e4a13c7Test

المؤلفون: Julien Mazieres, Balazs Halmos, David Vicente, Ali Tafreshi, Silvia Novello, Terufumi Kato, Bilal Piperdi, Jonathan Wilson, Mahmut Gumus, Jerónimo Rodríguez-Cid, Ki Hyeong Lee, Filiz Çay Şenler, Dariusz M. Kowalski, Shunichi Sugawara, Ying Cheng, Andrea Fülöp, Luis Paz-Ares, Keynote Investigators, Barbara Hermes, Alexander Luft, Gregory M. Lubiniecki, Tibor Csőszi, Xiaodong Li

المساهمون: Equipe Quantification en Imagerie Fonctionnelle (QuantIF-LITIS), Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), Université Le Havre Normandie (ULH), Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Université Le Havre Normandie (ULH), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)

المصدر: Transl Lung Cancer Res
The New England Journal of Medicine, 379, 2040-2051
The New England Journal of Medicine, 379, 21, pp. 2040-2051
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (21), pp.2040-2051. ⟨10.1056/NEJMoa1810865⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Lung Neoplasms, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Programmed Cell Death 1 Receptor, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Double-Blind Method, Female, Humans, Intention to Treat Analysis, Middle Aged, Paclitaxel, Progression-Free Survival, Survival Analysis, Pembrolizumab, chemistry.chemical_compound, 0302 clinical medicine, Monoclonal, 80 and over, Non-Small-Cell Lung, Humanized, General Medicine, 3. Good health, Editorial Commentary, 030220 oncology & carcinogenesis, medicine.medical_specialty, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Antibodies, 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Progression-free survival, Lung cancer, Survival analysis, Chemotherapy, business.industry, medicine.disease, respiratory tract diseases, 030104 developmental biology, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b08d70d621daefa6515103b791d7d01Test
https://hdl.handle.net/10668/13017Test